Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial - The Lancet Oncology
Kozena bunda Krivak - Vinted
Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4 - Basu - 2011 - The Prostate - Wiley Online Library